Increasing donor age adversely impacts beneficial effects of bone marrow but not smooth muscle myocardial cell therapy
Hao Zhang(Memorial Sloan Kettering Cancer Center), Ren‐Ke Li(Shanghai Institutes for Biological Sciences), Shafie Fazel(University Health Network), Donald A.G. Mickle(University Health Network), Hai Tian(Harbin Medical University), Takeshiro Fujii(University Health Network), Richard D. Weisel(University Health Network)
American Journal of Physiology-Heart and Circulatory Physiology
October 11, 2005
Cited by 123
Related Papers
Global, regional, and national time trends in mortality for congenital heart disease, 1990–2019: An age-period-cohort analysis for the Global Burden of Disease 2019 study
|EClinicalMedicine|2022|267
Berberine reduces insulin resistance through protein kinase C–dependent up-regulation of insulin receptor expression
|Metabolism|2008|265
Pathogenic variants damage cell composition and single cell transcription in cardiomyopathies
|Science|2022|235
Global Unmet Needs in Cardiac Surgery
|Global Heart|2018|209
pIRS: Profile-based Illumina pair-end reads simulator
|Bioinformatics|2012|207